title: The implications of sleep disruption for cognitive and affective processing in methamphetamine abuse.
abstract: Sleep is disrupted during active use of methamphetamine (MA), during withdrawal from the drug, and during abstinence from its use. However, relatively little is known about possible mediatory functions of disrupted sleep in the emergence, manifestation, and maintenance of cognitive and affective symptoms of MA abuse. We hypothesise that sleep functions as a mediator for stimulant drug effects. Specifically, we propose that objectively-measured sleep parameters can be used to explain some of the variability in the experience and presentation of memory deficits and emotion dysregulation in MA abusers. After describing how important healthy sleep is to unimpaired cognitive and affective functioning, we review literature describing how sleep is disrupted in MA abuse. Then, we provide a conceptual framework for our hypothesis by explaining the relationship between MA abuse, sleep disruption, memory deficits, emotion dysregulation, and changes in reward-related brain networks. We conclude by discussing implications of the hypothesis for research and treatment.
authors.affiliation: ACSENT Laboratory, Department of Psychology, University of Cape Town, South Africa.
authors.forename: Gosia
authors.initials: G
authors.lastname: Lipinska
authors.affiliation: ACSENT Laboratory, Department of Psychology, University of Cape Town, South Africa.
authors.forename: Ridwana
authors.initials: R
authors.lastname: Timol
authors.affiliation: ACSENT Laboratory, Department of Psychology, University of Cape Town, South Africa. Electronic address: kevin.thomas@uct.ac.za.
authors.forename: Kevin G F
authors.initials: KG
authors.lastname: Thomas
mesh_terms: D001519:Behavior; D001921:Brain / Q000503:physiopathology*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage; D003071:Cognition; D003072:Cognition Disorders / Q000150:complications / Q000503:physiopathology*; D004644:Emotions; D006801:Humans; D008568:Memory; D008694:Methamphetamine / Q000008:administration & dosage*; D012201:Reward; D012890:Sleep; D012893:Sleep Wake Disorders / Q000150:complications / Q000503:physiopathology*; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders / Q000503:physiopathology*
chemical_list: D000697:Central Nervous System Stimulants; D008694:Methamphetamine